Company: PACB
Filing Date: 2025-03-17
Form Type: 10-K
Source: 0001299130-25-000061
Chunk: 687

Company: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Filing Date: 2025-03-17
Form: 10-K
Item: Item 1A
Chunk 687
---
 their short maturities. 

Fiscal 2024 Form 10-K99

Assets and Liabilities Measured at Fair Value on a Recurring BasisThe following table sets forth the fair value of our financial assets and liabilities that were measured on a recurring basis:December 31, 2024December 31, 2023(in thousands)Level 1Level 2Level 3TotalLevel 1Level 2Level 3TotalAssetsCash and cash equivalents:Cash and money market funds $55,370 $— $— $55,370 $70,172 $— $— $70,172 Commercial paper — — — — — — — — U.S. government & agency securities— — — — — 109,739 — 109,739 Total cash and cash equivalents 55,370 — — 55,370 70,172 109,739 — 179,911 Investments:Commercial paper — — — — — 9,947 — 9,947 Corporate debt securities — 46,905 — 46,905 — 88,579 — 88,579 U.S. government & agency securities— 287,656 — 287,656 — 352,979 — 352,979 Total investments — 334,561 — 334,561 — 451,505 — 451,505 Short-term restricted cash690 — — 690 300 — — 300 Long-term restricted cash1,532 — — 1,532 2,422 — — 2,422 Total assets measured at fair value $57,592 $334,561 $— $392,153 $72,894 $561,244 $— $634,138 LiabilitiesContingent consideration - Apton acquisition$— $— $18,700 $18,700 $— $— $19,550 $19,550 Total liabilities measured at fair value $— $— $18,700 $18,700 $— $— $19,550 $19,550 For the year ended December 31, 2024, there were no transfers between Level 1, Level